PubRank
Search
About
N Sumar
Author PubWeight™ 26.15
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis.
Can J Gastroenterol
2000
2.18
2
Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy.
J Autoimmun
1991
1.45
3
Cytosolic glutamine synthetase in higher plants. A comparative immunological study.
Eur J Biochem
1984
1.20
4
Changes in normal glycosylation mechanisms in autoimmune rheumatic disease.
J Clin Invest
1992
1.11
5
IS900 targets translation initiation signals in Mycobacterium avium subsp. paratuberculosis to facilitate expression of its hed gene.
Microbiology
1997
1.05
6
Agalactosyl IgG: an aid to differential diagnosis in early synovitis.
Arthritis Rheum
1991
1.04
7
A low G+C content genetic island in Mycobacterium avium subsp. paratuberculosis and M. avium subsp. silvaticum with homologous genes in Mycobacterium tuberculosis.
Microbiology
1998
1.02
8
Measles virus and Crohn's disease.
Lancet
1995
1.02
9
Further studies on the GS element. A novel mycobacterial insertion sequence (IS1612), inserted into an acetylase gene (mpa) in Mycobacterium avium subsp. silvaticum but not in Mycobacterium avium subsp. paratuberculosis.
Vet Microbiol
2000
0.95
10
IgG glycosylation in autoimmune-prone strains of mice.
Clin Exp Immunol
1994
0.89
11
Cytokine profiles in stem cell transplantation: possible use as a predictor of graft-versus-host disease.
Hematology
2005
0.88
12
Lymphocytes from patients with rheumatoid arthritis produce agalactosylated IgG in vitro.
Clin Exp Immunol
1992
0.87
13
The utility of the ISAC allergen array in the investigation of idiopathic anaphylaxis.
Clin Exp Immunol
2014
0.85
14
Activation of human granulocyte type 1-prophospholipase A2.
Scand J Gastroenterol Suppl
1996
0.82
15
Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome.
Hum Reprod
2005
0.82
16
An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
Hum Reprod
2004
0.82
17
Reduced galactosyltransferase mRNA levels are associated with the agalactosyl IgG found in arthritis-prone MRL-lpr/lpr strain mice.
Immunology
1994
0.80
18
IgG and rheumatoid factor at a glance.
Clin Exp Rheumatol
1991
0.79
19
The forces driving autoimmune disease.
J Autoimmun
1992
0.79
20
Cholecystokinin-8 induces edematous pancreatitis in dogs associated with short burst of trypsinogen activation.
Dig Dis Sci
1995
0.79
21
Changes in glycosylation of IgG during fasting in patients with rheumatoid arthritis.
Br J Rheumatol
1996
0.78
22
Panel of anti-gp120 monoclonal antibodies reacts with same nuclear proteins in uninfected cells as those recognized by autoantibodies from patients with systemic lupus erythematosus.
AIDS Res Hum Retroviruses
1994
0.77
23
Type 1-prophospholipase A2 propeptide immunoreactivity is released from activated granulocytes.
Clin Biochem
1995
0.77
24
Type 1 prophospholipase A2 propeptide in acute lung injury.
Lancet
1994
0.77
25
Galactosylation of IgG associated oligosaccharides.
Lancet
1988
0.76
26
IgE-Mediated Anaphylaxis to Foods, Venom, and Drugs: Influence of Serum Angiotensin Converting Enzyme Levels and Genotype.
J Allergy (Cairo)
2012
0.76
27
The effect of serum concentration of leukaemia inhibitory factor on in vitro fertilization treatment outcome.
Am J Reprod Immunol
2006
0.76
28
Hyperenterostatinemia in premenopausal obese women.
J Clin Endocrinol Metab
1999
0.75
29
Comment on the article by Tomana et al.
Arthritis Rheum
1989
0.75
30
Cerebral trypsinogen expression in human and rat cerebrospinal fluid.
Neurosci Lett
2000
0.75
31
Agalactosyl IgG [Gal(o)]--an analysis of its clinical utility in the long-term follow-up of patients with rheumatoid arthritis.
Br J Rheumatol
1996
0.75
32
Distribution and characterization of enterostatin-like immunoreactivity in human cerebrospinal fluid.
Peptides
1998
0.75
33
Relationship of IgG glycosylation, soluble IL-2 receptors and IL-6 to disease activity in rheumatoid arthritis.
Br J Rheumatol
1994
0.75